肿瘤抑素的应用及研究进展

doi:10.11904/j.issn.1002-3070.2015.06.015

Abstract

Abstract: Growth of tumor need new blood vessel to meet the demand for adequate oxygen and nutrients.Inhibiting the formation of blood vessel can inhibit growth of tumor.In all of the endogenous angiogenesis inhibitors deriving from the type IV collagen.Study of tumstatin is the most widely.Tumstatin can inhibit endothelial proliferation and induce the apoptosis of endothelial cell.This article reviews the research status of the tumstatin.

Key words: Tumstatin, Apoptosis, Proliferation, Blood

CLC Number:

R730.43

YU Qian, WANG Jijun, ZHU Jiang, HE Yan. The application and research progress of Tumstatin[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(6): 549-552.

References

1 Peter C,Rakesh KJ.Angiogenesis in cancer and other disease[J].Nature,2000,407(6801):249-257.
2 明平坡,戈伟,介芳,等.恩度联合放疗对Lewis肺癌小鼠MVD及αvβ3mRNA表达的影响[C].实用肿瘤学杂志,2014,28(1):1002-3070.
3 Esipov R,Beyrakhova K,Likhvantseva V,et al.Antiangiogenic and antivascular effects of a recombinant tumstatin-derived peptide in a corneal neovascularization mode[J].Biochime,2012,96(6):1368-1375.
4 Zhang LL,Liu J,Lei S,et al.Pten inhibits the invasion and metastasis of gastric cancer via downregulation of fak expression[J].Cell Signal,2014 26(5):1011-1020.
5 Maeshima Y,Colorado Pc,Kalluri R.Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties[J].J Biol Chem,2000,275(31):23745-23750.
6 Xie L,Duncan MB,Pahler J,et al.Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner[J].Proc Natl Acad Sci U S A,2011,108(24):9939-9944.
7 Sudhakar A,Boosani CS.Inhibition of tumor angiogenesis by tumstatin:Insights into signaling mechanisms and implications in cancer regression[J].Pharm Res,2008,25(12):2731-2739.
8 Teodoro JG,Parker AE,Zhu X.P53-mediated inhibition of angiogenesis through up-regulation of a collagenprolylhydroxylase[J].Science,2006,313(5789):968-971.
9 贺欣,赵启仁,宋娜玲,等.肿瘤抑素活性肽段及其衍生物研究新进展[J].药学服务与研究,2007,7(5):335-338.
10 Hamano Y,Zeisberg M,Suqimoto H,et al.Physiological levels of tumstatin,a fragment of collagen IV alpha3 chain,are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin[J].Cancer Cell,2003,3(6):589-601.
11 Borza CM,Pozzi A,Borza DB,et al.Integrin α3β1,a novel receptor for α3(IV)noncollagenous domain and a tans-dominant inhibitor for integrin αvβ3[J].J Biol Chem,2006,281(30):20932-20939.
12 周明,罗以勤.肿瘤血管生成抑制因子tumstatin 的研究进展[J].临床输血与检验,2012,74(3):1617-2587.
13 Boosani CS,Mannam AP,Cosgrove D,et al.Regulation of Cox-2-mediated signaling by α3 type IV noncollagenous domain in tumor angiogenesis[J].Blood,2007,110(4):1168-1177.
14 Homano Y,Zeisberg M,Sugimoto H,et al.Physiological levels of tumstatin,a fragment of collagen IV α3 chain are generated by MMP-9 proteolysis and supress angiogenesis via αvβ3integin[J].Cancer Cell,2003,3(6):589-601.
15 Eikesdal HP,Sugimoto H,Birrane G,et al.Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity[J].P Natl Acad Sci USA,2008,105(39):15040-15045.
16 Thevenard J,Ramont L,Devy J,et al.The YSNSG cyclopeptide derived from tumstatin inhibits tumor angiogenesis by down-regulating endothelial cell migration[J].Int J Cancer,2010,126(5):1055-1066.
17 王军鹏.肿瘤抑素活性肽-YSNSG环肽研究新进展[J].黑龙江医学,2009,3(12):902-903.
18 Suzuki A,Sasaki T,Mak TW,et al.Role of Pten/PI3K pathway in endothelial cells[J].Biochem Soc Trans,2007,35(2):172-176.
19 Maeshima Y,Sudhakar A,Lively JC,et al.Tumstatin,an endothelial cell-specific inhibitor of protein synthesis[J].Science,2002,295(5552):140-143.
20 Wang F,Dong X,Xu Z,et al.T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy[J].Oncol Rep,2015,33(2):675-684.
21 Gu Q,Sun C,Zhang T,et al.Inhibition of angiogenesis by a synthetic fusion protein VTF derived from vasostatin and tumstatin[J].Anticancer Drugs,2014,25(9):1044-1051.
22 Xu CX,Liu X,Hou GS,et al.The expression of tumstatin is down-regulated in renal carcinoma[J].Mol Biol Rep,2010,37(5):2273-2277.
23 Li J,Luo YQ,Luo J.Overexpression of tumstatin in genetically modified megakaryocytes changes the proangiogenic effect of platelets[J].Transfusion,2014,54(8):2106-2117.

[1]	LIU Zhiqiang,CHU Yanjie,LIU Jing,WANG Yanbo. Atractylenolide I regulates proliferation and invasion of lung cancer A549 cells through the TLR4/MyD88 pathway [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 228-232.
[2]	BAI Xiaobin, HUO Longwei, XIE Wanfu, XU Gaofeng, WANG Maode. Expression of Chk1 in glioblastoma and its association with tumor biological behavior and prognosis survival [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 122-127.
[3]	YUAN Guixia, LI Yan, FENG Wanqi, XIA Xiaojuan, LI Xu. Mechanism of tumor suppressor gene DKK2 inhibiting proliferation of nephroblastoma cells in children [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 14-20.
[4]	SONG Ling, FU Qiong. Study of the effect of astragalin on proliferation of ovarian cancer cells by inhibiting the glycolytic pathway induced Via HIF-1α [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 503-509.
[5]	LIU Juan, ZHANG Shutian. Advances in research on the mechanism of cyclin-dependent kinase inhibitor 3(CDKN3)in tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 575-578.
[6]	LI Wanzhen, YIN Jun, LI Ping, LIN Xiaohui, ZHANG Guoqian, ZHANG Shuxu. The expression and role of miR-17 in radioresistant cells of non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 391-397.
[7]	CHEN Lin, WANG Enxiang, LIU Qunyou, ZHONG Ying, ZHOU Guoliang, ZHAO Xiyan. CDX2 gene inhibits of colon cancer cell proliferation by NF-κB signaling pathway [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 398-403.
[8]	KONG Fanwei, ZHAO Changjiu. The change of peripheral blood cells after iodine 131 treatment in differentiation thyroid cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 476-479.
[9]	CHEN Zhaohong,HE Yingying,ZHANG Youcai,LU Dingyu. Effects of SOX7 overexpression on proliferation and other biological characteristics of gallbladder carcinoma GBC-SD cells and its mechanism [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 293-297.
[10]	LI Wenhui, LV Bowen, QIAN Jun, SU Liju, YANG Tongshu, QIAN Jingrong, WANG Jie. Effect of microRNA-150 on proliferation,apoptosis,invasion and metastasis of epithelial ovarian cancer cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 208-213.
[11]	FAN Ningning, GENG Jingshu. The expression and role of LncRNA MEG3 in human glioma cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 219-223.
[12]	DUAN Yanjun, XU Wei, CHEN Wenjie, WANG Fengjuan. Effects of Wnt pathway inhibitor ETC-159 on proliferation and migration of OSCC cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 103-106.
[13]	LI Yipeng, ZHANG Xinyu, LV Hanning, SUN Lichun. Research progression of MLLT6 in leukemia [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 135-139.
[14]	WANG Xiaoxiao, HUA Teng, WANG Hongbo. Research progress of estrogen receptor-related receptor γ in tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 87-91.
[15]	MENG Yongsheng. Effect of lycopene on the growth of human osteosarcoma cells and its mechanism [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 506-511.

The application and research progress of Tumstatin

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments